Trial
NCT03387111
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Squamous Cell Carcinoma
Intervention
Aldoxorubicin HCl
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-05